Episode Details

Naman Julka-Anderson and Jo McNamara catch up with Úna Findlay as part of the leadership series (part 23).

Discussion about Úna’s career, transferable skills of therapeutic radiographer and future plans at the UK Health Security Agency.

To use this podcast as CPD, look at these reflection points: 

1. Reflect upon your current practice and consider how you can improve/ influence patient safety. 
2. Reread Toward Safer Radiotherapy. Have all recommendations being implemented in your work area? If you work in Clinical Radiology or Nuclear Medicine, many of the recommendations have transferable learning.

Complete this form for your accredited digital badge: https://bit.ly/3GbtR1X.

Links from podcast:

Further information on the work of the Medical Exposures Group:

• https://www.ukhsa-protectionservices.org.uk/meg

Safer Radiotherapy publications:

• Triannual report
• e-Bulletin
• Webpage
• eSubscribe

Incident learning in clinical imaging, MRI and nuclear medicine:

• User guidance and application of the national taxonomy for incident learning in clinical imaging, MRI and nuclear medicine
• National coding taxonomy for incident learning in clinical imaging, MRI and nuclear medicine

Better Nuclear Medicine Practice:

• ARSAC notes for guidance: good clinical practice in nuclear medicine

Please like and subscribe to Rad Chat on your podcast library.

Our links:

Link Tree:https://linktr.ee/radchat 

Facebook:https://www.facebook.com/RadChatPodcast/ 

Instagram:https://www.instagram.com/rad__chat/ 

LinkedIn:https://uk.linkedin.com/company/radtalk 

Tik Tok:https://www.tiktok.com/@rad_chat 

Twitter:https://twitter.com/rad__chat?lang=en 

YouTube: https://www.youtube.com/@radchat2259

Music and jingle credits: Dr. Ben Potts and Adam Cooke.

© Rad Chat 2025. All rights reserved.  

We (or our licensors) own all intellectual property rights in this podcast and all related content, online and offline.  

You may not use, copy, modify, download, archive, reproduce, distribute, display, publish, licence, create derivative works from or commercially exploit any part of our content unless we expressly agree in writing.  

You must not u